Compare and contrast clinical health services to public health and epidemiology in terms of a) how they are defined, b) goals, c) their target focus and d) functions.
Question 2. Question :
Managerial epidemiology is integrated through general management functions. Explain each of the management functions in terms of the managerial epidemiology, i.e., what are the:
a. Planning functions, example(s)?
b. Directing functions, example(s)?
c. Controlling functions, example(s)?
d. Organizing functions, example(s)?
e. Financing function, example(s)?
Question 3. Question :
Describe the “natural history of disease” and disease progression from its inception to its resolution.
Question 4. Question :
What are some of the many epidemiologic contributions to quality assurance in healthcare and public health?
Question 5. Question :
December 31, 2009: A 48 year old male computer technician with hypertension, smoker, sedentary lifestyle, who does not do any aerobic exercise, enjoys fast food, eating it three times per day, with a family history of coronary artery disease (CAD), and a personal history of high cholesterol has a stressful deadline at work, which requires him to travel 17 hours on a plan to go on location in Australia. Unfortunately, he suffers an acute myocardial infarction in route to location and dies. He is now part of our epidemiology population mortality statistics. Calculate the U.S. Mortality Rates, which includes our computer technician in terms of crude rate of mortality, adjusted mortality rates and cause-Specific mortality rate using the 2009 statistics.
Input Data for Calculations:
___________________
-2009 U.S. Census: 305,529,237 Total
-2009 U.S. Census: Males 148,094,000
-2009 U.S. Census: Females 153,388,000
Population by Age and Sex: 2009
Age
Both sexes
Male
Female
Number
Percent
Number
Percent
Number
Percent
.35 to 39
20,445
6.8
10,169
6.9
10,275
6.7
.40 to 44
20,877
6.9
10,322
7.0
10,556
6.9
.45 to 49
22,712
7.5
11,162
7.5
11,550
7.5
.50 to 54
21,654
7.2
10,611
7.2
11,043
7.2
.55 to 59
18,755
6.2
9,083
6.1
9,671
6.3
___________________
-2009 U.S. Deaths: 2,436,682
-2009 U.S. Male Deaths 1,217,047
-2009 U.S. Female Deaths 1,219,635
___________________
2009 Deaths By Gender/Age All races, male
All ages……………1,217,047
1-4 years………………14,872
5-14 years………………2,507
15-24 years…….………3,244
25-34 years…..………22,294
35-44 years……………29,150
45-54 years……………46,498
55-64 years…….……114,615
65-74 years…….……183,945
75-74 years…….……225,740
75-84 years…….……311,135
>=85 years…….……262,839
Not stated……………………206
2009 CVD/ Heart Attack Mortality,
Male/Age
Age (All)
186,464
35-44
55,957
45-54
115,615
55-64
276,844
65-74
677,598
Source: CDC (2009)
________________
Case Questions:
a. Calculate the Crude mortality rate for the entire U.S. in 2009.
b. Calculate a total adjusted mortality rates by gender for all men (males-only).
c. Calculate an age/sex adjusted mortality rate using the demographics of the diseased computer technician.
d. Compare b) morality rate calculated with c) mortality rate calculated. Is the adjusted mortality rate for males, age 45-54 years of age higher or lower than for all males, all ages?
e. Calculate a Cause-Specific mortality rate for deaths related to Cardiovascular Disease (Heart Attacks), using the demographics of our computer technician.
Question 6. Question :
Case Study #1: 2.1. Food poisoning outbreak at Bluegrass Hospital
An outbreak of food poisoning occurred among the 400 staff and patients at Bluegrass Hospital a few hours after eating dinner. Among the 60 people who became ill, the Symptoms were mainly nausea, vomiting and diarrhea. The infection control nurse investigated the outbreak and reported results in
Table 2.5 Below
Case1Midterm
____________________
Questions: 5 pts each
1. What is the “crude” attack rate?
2. What are the food-specific attack rates for those who consumed, and did not consume each food item?
3. How many times more likely are people who consumed specific food items to get sick compared to those who did not consume each item?
4. Which food item is the most likely cause of this “common source” outbreak?
5. What are the incubation period and most likely cause of the outbreak?
Question 7. Question :
Case Study #2: Osteoporosis Marketing Plan
You are the Director of Community Relations, reporting to the Chief Operating Officer (COO) at Allright Memorial Hospital, Anywhere, USA. You have been asked by your COO to spearhead a community council with local public health officials, who will be focused on women over 50 for the prevention of osteoporosis. Your committee’s strategic plan SWOT analyses revealed the following information.
_________
Background:
The purpose of this project is to create an intervention prevention program that minimizes osteoporosis in women over 50 and with the health risks associated with the condition for Anywhere, USA. Per the Centers for Medicare and Medicaid (CMS), abstracted from medical claims data, “an estimated 10 million Americans have osteoporosis and 34 million Americans have low bone mass, placing them at an increased risk for osteoporosis. An analysis, using the Anywhere, USA state hospital database shows a slightly higher rate of risk than the national average. The report shows that osteoporosis is responsible for more than 1.5 million fractures annually, including 300,000 hip fractures, 700,000 vertebral fractures, 250,000 wrist fractures, and more than 300,000 fractures of other sites. Osteoporosis can be prevented. Early diagnosis and treatment can reduce or prevent fractures from occurring”. (CMS 2007)
The Committee Objectives:
1. To research and identify best community partners and interventions for prevention of high risk osteoporosis residents in Anywhere, USA.
2. To use create a health promotion marketing plan for early bone density screening targeted throughout the Anywhere, USA communities.
Targets: At Risk Population for Osteoporosis
Age: Postmenopausal woman over >= 50 years of age
Race: Caucasian, Asian, African-American and Hispanic women
History: Women who have a family or personal history of fractures after age 50
Health Conditions: Women who have menopause before the age of 45 due to a medical condition or unknown cause.
Healh Behaviors: Women who have premature menopause due to anorexia, bulimia, tabacco and alcohol use, or excessive exercise.
Nutrient Deficiencies: Calcium and/or vitamin D deficiency
Lifestyle: Sedentary, inactive lifestyle
Medical Treatements: Steroid (corticosteroids), radiation and/or chemotherapy treatments
Source: NIH 2010, Chart: Meyer 2010
________________
Case Questions:
1. Using reliable primary resources do research and determine who the best community partners, and the most effective interventions for prevention promotion for high risk osteoporosis residents in Anywhere, USA. Your own hospital is one community partner, and it radiology services (bone density machines) are a resource. What other and resources within the community would be appropriate?
2. Create a health promotion marketing plan for early bone density screening targeted throughout the Anywhere, USA communities using the 4-Ps. Your marketing plan also needs a mission statement, a statement of purpose, objectives and timelines of how you will implement the program.
final
1
Managerial Epidemiology: What is the cost-effectiveness analysis and what is it used for in healthcare and public health? Provide an example study.
Question 2. Question :
Qualitative, Quantitative (Cause-Effect): You are the Chief Operating Officer of a hospital. The Human Resources Director reports to you. Two of your valued Directors have a random drug screening for controlled substances with a group of hospital cohorts, and the result comes up as positive for heroine. Your experience with epidemiology and your understanding of cause-effect makes you skeptical of these general screening results. You request that the specimens be sent out to a specialty lab for confirmatory testing with gas chromatography specific for heroine. The results of the confirmatory testing show that both Directors are negative (0 mg/dl) for all control substances, including heroine. A further investigation revealed that both Directors attended a morning meeting the day of the random test and had eaten poppy seed muffins. You do research and find that poppy seed muffins produce a byproduct in the body that mimics opiates/heroine in a screening.
Discuss why these results occurred , i.e., the two very different results between a screening, and the confirmatory test in terms of a) qualitative and b) quantitative testing, c) specificity, d) reliability.
Question 3. Question :
Research Methods: Why is the randomized clinical trial (RCT) research considered the “gold standard” in clinical epidemiology research? What is an IRB and why is it requirement when performing research with human beings?
Question 4. Question :
Decision Making: Clinical epidemiology research should be based on empirical evident. Define empirical evidence and what it means in decision making in both private and public health decision making in regard to interventions, i.e., the implementation of medical testing, processes or public health programs.
Question 5. Question :
Risk Factor Research: Why is the Framingham Heart Study a pivotal research program in healthcare today? What are some of the milestones the study has given to clinical epidemiology?
Question 6. Question :
Case 1 of 2 (50 Pts): Cost-Effectiveness Analysis (CEA): In Wu et al. (2006) researchers performed an analysis to evaluate the cost-effectiveness of doing stool DNA testing in addition to other types of traditional screenings, i.e., fecal occult blood testing annually, flexible sigmoidoscopy or colonoscopy, every 5 and 10 years for colorectal cancer in countries where colon cancer prevalence is low. Also, evaluated was the cost/benefit of doing no screenings (Wu, 2006).
The subjects were people 50 to 75 years of age in Taiwan. The researchers used the annual cost of $13,000 per life-year saved (which is roughly the per capita GNP of) as the ceiling ratio for assessing whether DNA testing was cost-effective (Wu, 2006).
Simulated results for screening strategies to prevent Colon Rectal Cancer (CRC)
Variable
Screening Strategy
No Screening
DNA (3yrs)
DNA (5yrs)
DNA (10yrs)
Occult Blood
Flexible Sigmoid. (5yrs)
Colonoscopy (10 yrs)
a. Total cases of CRC, n
2,917
2,435
2,654
2,710
2,129
2,253
1,780
b. CRC deaths, n
1,729
1,345
1,467
1,574
1,059
1,328
1,077
c. Perforation deaths, n
0
3
2
1
5
3
12
e. Reduction in CRC incidence, %
0
17
9
7
27
23
39
f. Reduction in CRC mortality, %
0
22
15
9
39
23
39
g. Life expectancy, year
15.7337
15.7476
15.7434
15.74
15.7584
15.7477
15.759
h. Total costs, thousand $
22,022
35,637
31,077
26,856
19,824
24,909
21,843
i. Incremental life-year saved, year
0
1,390
970
626
2,464
1,383
2,530
j. Incremental cost, thousand $
0
13,615
9,054
4,834
-2,198
2,887
-180
k. Incremental cost ($)/life-years saved compared with no screening
0
9,794
9,335
7,717
Dominant ‡
2,087
Dominant †
* Values obtain from a cohort of 100,000 persons 50 years of age who were followed for 25 years.
† The other screening strategy is more effective and less costly than stool DNA testing strategy.
‡ The screening is more effective and less costly than No Screening.
Adapted from: Wu et al. BMC Cancer 2006 6:136 doi:10.1186/1471-2407-6-136
_____________
Reference:
Wu, Grace HM. Wang, Yi-Ming . Yen, Amy MF. Wong, Jau-Min Lai, Hsin-Chih Warwick, Jane and Chen, Tony HH. (2006) Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. BMC Cancer 2006, 6:136 doi:10.1186/1471-2407-6-136
QUESTIONS: In your own words and
1) From the research results shown in the chart above, which type of screening had the highest and which had the lowest reduction in colon-rectal cancer mortality?
2) How do you interpret the findings (Conclusion) in regard to the A-K results in regard to the cost/effectives of doing DNA-testing at 3 years, 5 years, 10 years, or not doing DNA tests at all?
Question 7. Question :
NOTE: Essay Question is in 2 parts. This is Part 1 to be completed and then go <next>, to Part 2 and complete it.
Case #2 of 2: (50 pts) Cost/Benefit literature review for vaginal birth after cesarean (VBAC)
A client had a cesarean delivery in a hospital setting for breech presentation with her first pregnancy. She is pregnant again and after exploring her delivery options, has decided she wants to attempt a vaginal birth after cesarean (VBAC). She has had an uncomplicated pregnancy this time and the fetus is not breech. The same OB-GYN will be assisting in her delivery. The OB-GYN performs a systematic review of the literature to assess the benefits and harms of VBAC versus repeat cesarean delivery.
Part 1 of 2: Researching Empirical Evidence
1. What kinds and sources of data does the OB-GYN need to review in order to make a rational clinical planning decision?
2. Which types of studies available on this topic would be the most useful in clinical decision making?
3. What types of studies would you want to exclude?
4. Why would there be a lack of randomized clinical trials (RCT’s) available to address this clinical question?
Question 8. Question :
NOTE: This is Part 2 of the final essay question: The last essay question requires you to do a 2x2 table in addition to calculations. The tables may be done by copying the table from the question directly into your answer and then filling the table out.
Case: Calculating Odds Ratio
In planning for her delivery, the client reads about birthing centers and asks the midwife if it is safe to have a VBAC in a freestanding birthing center. The midwife reviews the data from national studies of VBACs in birthing centers compared to VBACs in hospital settings and obtains the following statistics to aid her in clinical decision making:
N= 1913 Birthing Center based VBAC Rates
• 87% delivered vaginally
• 24% of women were transferred to the hospital prior to delivery
• There were 25 women who experienced a serious adverse outcome (of which 6 were uterine rupture)
• There were 7 perinatal deaths (0.5%)
• There were 15 infants with low apgar scores (below 7) after 5 minutes of life (1.0%)
N= 1913 Hospital based VBAC Rates (Control)
• 76% delivered vaginally
• There were 32 women who experienced a serious adverse outcome (of which 15 were uterine ruptures)
• There were 3 perinatal deaths
• There were 2 infants with low apgar scores (less than 7) after 5 minutes of life
(Part 2 of 2): Construct the following for 1 and 2 and answer question 3
1. Construct a 2 x 2 table, calculate, and interpret the odds ratio of women who suffered a serious adverse outcome from attempting a VBAC delivery in order to estimate the relative risk to a mother delivering VBAC in midwifery based freestanding birthing centers. Cases are those with a serious outcome, controls are those without. The exposure is treatment in a birthing center. The not exposed group is treatment in a hospital.
Exposure
Cases
Controls
Birthing Center
Hospital
2. Construct a 2 x 2 table, calculate, and interpret the odds ratio of infants who suffered a serious adverse outcome (including death) from attempting a VBAC delivery in order to estimate the relative risk to an infant delivered VBAC in midwifery based freestanding
Cases
Controls
3. What does the midwife conclude regarding the safety to mother and baby by attempting a VBAC in midwifery based birthing centers? What clinically is the best decision for this client and her unborn baby?
in (GMT-05:00) Eastern Time (US & Canada)
Solution: saint HCM530 full course [ all discussions all case study midterm final except module 7 case study